Enhancing the effectiveness of radiation therapy in brain cancer

BrachyThermix is a start up oncology device company formed in 2018, based in the Philadelphia area.  

In partnership with Thomas Jefferson University, BrachyThermix is developing a novel technology to significantly enhance the therapeutic benefit of radiation treatment following surgical resection of difficult to treat brain tumors such as glioblastoma.

Leave a Reply

Your email address will not be published. Required fields are marked *